Results tagged “yaz” from New Mexico Injury Lawyer Blog

December 9, 2011

Yaz Required To Provide New Information On Warning Labels

The Food and Drug Administration (FDA) has recently issued documents recommending that birth control pills such as Yaz should contain additional warnings concerning the risk of blood clots. The FDA noted that patients and doctors should be informed about the risks. A statement from FDA scientists provides, "We believe that, because of the consistency in recent reports for an increased risk, product labeling should reflect that very real possibility."

A predecessor to Yaz, Yasmin, was the first birth control pill using drospirenone, a new form of progestin. In 2006 Yasmin was reformulated and sold as Yaz. Although it was originally thought to have fewer side effects than older contraceptives, Yaz has now been shown to have a higher risk of blood clots than earlier types of birth control pills.

If you or a loved one has taken Yaz or other birth control pill containing drospirenone it is important to speak to a New Mexico Yaz attorney to determine your next steps. Birth control pills such as Yaz, Yasmin or Ocella have been associated with several side effects in addition to blood clots including:

• stroke
• heart attack
• gallbladder disease

The FDA will also ask a panel of experts to provide advice whether the drug is too dangerous for some women to take.

Continue reading "Yaz Required To Provide New Information On Warning Labels" »

June 1, 2011

Yaz Investigated For Increased Risk Of Blood Clots

Many types of birth control pills create risks of blood clots. However, new birth control research suggests that certain types of pills create an even higher risk of blood clots than others. Birth control pills that contain drospirenone - such as Yaz, Yasmin and Beyaz contain a two to three time higher risk for developing blot clots than other types of pills.

Yaz and Yasmin have been under fire for several years as a result of their potentially dangerous side effects including increased risk of death and stroke. With the added increased risk of blood clots, as well as gall bladder disease, women are urged to speak to a physician about alternatives to this dangerous drug.

Two recent studies released in the British Medical Journal determine that the risk from taking drospirenone is significantly higher than taking pills containing levonorgestrel. The FDA responded in an alert "the FDA ...will look at all currently available information to fully assess the risks and benefits of drospirenone-containing birth control pills."

Continue reading "Yaz Investigated For Increased Risk Of Blood Clots" »